BioLineRx Ltd. (BLRX)
3.26
-0.06
(-1.81%)
USD |
NASDAQ |
Dec 09, 16:00
3.26
0.00 (0.00%)
After-Hours: 18:30
BioLineRx Profit Margin (Quarterly): -228.8% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -369.1% |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -- |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.74% |
| Return on Assets | -7.08% |
| Return on Invested Capital | -9.37% |
| Gross Profit Margin (Quarterly) | 52.45% |
| Operating Margin (Quarterly) | -516.9% |
| Return on Net Operating Assets | -17.82% |